Inhibrx Biosciences CEO Mark Lappe buys $849,000 of shares
Open market purchase reported on Form 4, filed Oct 14, 2026.
Snapshot
Mark Lappe, Chief Executive Officer of Inhibrx Biosciences (INBX), bought 10,040 shares in open market purchases on Oct 14, 2026, about $849,000 at an average price of $84.56 a share, according to a Form 4 filed with the SEC on Oct 14, 2026.
- Independent Research
Market Data
| Company | 1D % | Price |
|---|---|---|
| ($INBX) | ▲ +6.14% | 95.30 |
as of 16:00 ET · Realtime derived data
What We Know
The filing lists 6 open market purchase lines: • Oct 14, 2026: 2,470 shares at $84.07. • Oct 14, 2026: 2,470 shares at $85.00. • Oct 14, 2026: 100 shares at $85.76. • Oct 14, 2026: 2,449 shares at $84.07. • Oct 14, 2026: 2,451 shares at $85.00. • Oct 14, 2026: 100 shares at $85.76.
After the last purchase, the filing reports 170,000 shares held indirectly in that account.
Octans View
The purchases raised the holding reported in that account by about 6.3%, computed from the filed share counts. An open market purchase is made with the insider's own money at the market price, unlike option exercises or stock awards, which this brief excludes. The filing does not say why the insider bought.
Bear Case · Room for Disagreement
Limits. Insiders must report trades within two business days; this brief covers one filing and does not net it against sales by the same person or other insiders. Prices are as filed; where a line shows a weighted average, the filing's footnotes give the range.
Method and source. Octans Research reads the structured Form 4 filed with the SEC, keeps open market purchases (code P) only, and computes the total value and the average price from the filed share counts and prices. The filed price must sit within 25% of the closing price on the trade date. The text is generated by a fixed template; no model wrote it.
Chart
Sources
- [1]SEC EDGAR — Form 4 filed by Mark Lappe for Inhibrx Biosciences, Oct 14, 2026
These are the sources this piece was drafted from. How we verify. Found an error? Tell us and we correct it in public.
More on $INBX
4 reports
SenesTech 10% owner Glenbrook Capital Management buys $706,000 of shares
Open market purchase reported on Form 4, filed Oct 19, 2026.
Applied Digital CEO Wes Cummins buys $1.0 million of shares
Open market purchase reported on Form 4, filed Oct 19, 2026.
Bluerock Private Real Estate Fund director Ramin Kamfar buys $2.4 million of shares
Open market purchase reported on Form 4, filed Oct 19, 2026.
Applied Digital president Jason Gechen Zhang buys $5.7 million of shares
Open market purchase reported on Form 4, filed Oct 19, 2026.